173 related articles for article (PubMed ID: 8775253)
1. Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience.
Aust N Z J Obstet Gynaecol; 1996 Feb; 36(1):55-60. PubMed ID: 8775253
[TBL] [Abstract][Full Text] [Related]
2. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team.
Shaw RW
Fertil Steril; 1992 Aug; 58(2):265-72. PubMed ID: 1386029
[TBL] [Abstract][Full Text] [Related]
3. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
Rock JA; Truglia JA; Caplan RJ
Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
[TBL] [Abstract][Full Text] [Related]
4. Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis.
Rotondi M; Labriola D; Rotondi M; Ammaturo FP; Amato G; Carella C; Izzo A; Panariello S
Eur J Gynaecol Oncol; 2002; 23(6):523-6. PubMed ID: 12556096
[TBL] [Abstract][Full Text] [Related]
5. Goserelin (Zoladex) versus danazol for endometriosis: the North American experience.
Damario MA; Rock JA
Br J Obstet Gynaecol; 1994 May; 101 Suppl 10():13-8. PubMed ID: 8199097
[No Abstract] [Full Text] [Related]
6. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia.
Fraser IS; Healy DL; Torode H; Song JY; Mamers P; Wilde F
Obstet Gynecol; 1996 Apr; 87(4):544-50. PubMed ID: 8602306
[TBL] [Abstract][Full Text] [Related]
7. Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments.
Matalliotakis IM; Koumantaki YG; Neonaki MA; Goumenou AG; Koumantakis GE; Kyriakou DS; Koumantakis EE
Am J Obstet Gynecol; 2000 Jul; 183(1):58-62. PubMed ID: 10920309
[TBL] [Abstract][Full Text] [Related]
8. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.
Perry CM; Brogden RN
Drugs; 1996 Feb; 51(2):319-46. PubMed ID: 8808170
[TBL] [Abstract][Full Text] [Related]
9. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents.
Sculpher M; Thompson E; Brown J; Garry R
BJOG; 2000 Mar; 107(3):340-6. PubMed ID: 10740330
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis.
Matalliotakis IM; Arici A; Goumenou AG; Katassos T; Karkavitsas N; Koumantakis EE
Int J Fertil Womens Med; 2004; 49(2):75-8. PubMed ID: 15188832
[TBL] [Abstract][Full Text] [Related]
11. Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial.
Crosignani PG; Gastaldi A; Lombardi PL; Montemagno U; Vignali M; Serra GB; Stella C
Clin Ther; 1992; 14 Suppl A():29-36. PubMed ID: 1535020
[TBL] [Abstract][Full Text] [Related]
12. Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis.
Magini A; Pellegrini S; Tavella K; Forti G; Massi GB; Serio M
J Endocrinol Invest; 1993 Nov; 16(10):775-80. PubMed ID: 8144850
[TBL] [Abstract][Full Text] [Related]
13. Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results.
Wheeler JM; Knittle JD; Miller JD
Am J Obstet Gynecol; 1992 Nov; 167(5):1367-71. PubMed ID: 1442992
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and tolerance of a gonadotropin releasing hormone (goserelin) in treatment of symptomatic endometriosis].
Wenzl R; Schultes G; Stummvoll W; Wieser F; Husslein P
Wien Klin Wochenschr; 1999 Apr; 111(7):283-8. PubMed ID: 10355039
[TBL] [Abstract][Full Text] [Related]
15. Danazol linked to ovarian cancer.
Weideman M
Lancet Oncol; 2002 May; 3(5):261. PubMed ID: 12067790
[No Abstract] [Full Text] [Related]
16. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
Stevenson JC; Lees B; Gardner R; Shaw RW
Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
[TBL] [Abstract][Full Text] [Related]
19. Updating the clinical experience in endometriosis--the Brazilian perspective.
Halbe HW; Nakamura MS; Da Silveira GP; Carvalho WP
Br J Obstet Gynaecol; 1995 Oct; 102 Suppl 12():17-21. PubMed ID: 7577850
[TBL] [Abstract][Full Text] [Related]
20. Goserelin versus danazol in the treatment of endometriosis.
Giorgino FL; Cetera C; de Laurentiis G
Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
